Etiology and Treatment of Alcohol Dependence

$1,682,796P60FY2016AANIH

University Of Connecticut Sch Of Med/Dnt, Farmington CT

Investigators

Linked publications & trials

Paper 39555136 Paper 38684046 Paper 38225874 Paper 37004447 Paper 36971759 Paper 36107642 Paper 35728089 Paper 35229945 Paper 34712519 Paper 34545657 Paper 34225029 Paper 34120366 Paper 34049101 Paper 33818193 Paper 33793278 Paper 33138928 Paper 33029895 Paper 32911355 Paper 32745946 Paper 32701168 Paper 32622025 Paper 32574382 Paper 32039621 Paper 31955720 Paper 31931271 Paper 31442882 Paper 31436886 Paper 31343197 Paper 31343196 Paper 30959414 Paper 30930609 Paper 30862775 Paper 30710610 Paper 30537098 Paper 30308286 Paper 30307258 Paper 30265039 Paper 30170301 Paper 29777461 Paper 29734827 Paper 29723083 Paper 29461070 Paper 29423990 Paper 29289852 Paper 29156239 Paper 29129191 Paper 28921996 Paper 28745446 Paper 28728460 Paper 28709081 Paper 28672076 Paper 28639817 Paper 28639812 Paper 28630458 Paper 28476266 Paper 28042525 Paper 27915167 Paper 27896905 Paper 27750317 Paper 27746057 Paper 27635675 Paper 27613901 Paper 27536011 Paper 27536009 Paper 27492676 Paper 27449226 Paper 27398781 Paper 27196697 Paper 27051333 Paper 27020748 Paper 26894560 Paper 26894551 Paper 26891181 Paper 26885470 Paper 26817621 Paper 26812684 Paper 26716877 Paper 26716875 Paper 26691066 Paper 26682582 Paper 26669531 Paper 26589363 Paper 26580209 Paper 26408026 Paper 26388585 Paper 26250693 Paper 26244381 Paper 26237326 Paper 26232136 Paper 26216590 Paper 26203061 Paper 26184649 Paper 26173161 Paper 26167714 Paper 26098033 Paper 26044610 Paper 25953963 Paper 25879250 Paper 25832883 Paper 25821660

Abstract

DESCRIPTION (provided by applicant): This P60 application from the University of Connecticut Alcohol Research Center (UCONN ARC) requests five years of continued funding for the Center's research programs on vulnerability to alcohol dependence and promising biological and psychosocial treatment interventions. Component I describes the UConn ARC's organizational framework, quality control mechanisms related to research and publications, and supporting research facilities. The visiting scholars program, consulting and mentoring activities and journal editorship activities strengthen the UConn ARC'S role as a regional and national resource. Component II focuses on neurophysiologic, psychological, and genetic factors to predict risky drinking behavior / binge drinking and obesity risk among college age females. Component III, a second study of vulnerability, will focus on several stress-related pathways (including genetic) that may increase the susceptibility for developing heavy drinking and alcohol-related problems among college students after graduation. Continuing our Center's emphasis on novel treatments, we propose two new studies. Component IV builds upon current work and will evaluate the efficacy of Contingency Management as alcohol use is continuously monitored electronically vs. standard treatment. Eighteen month follow-up evaluations will examine drinking outcomes and the effects of CM on reducing other drug use, psychosocial problems, predictors of relapse, and the interaction of GABRA2 genotype with treatment conditions. Component V is a placebo controlled trial to evaluate the safety and efficacy of dutasteride. Reductions in drinking, the persistence of treatment effects, and the role of GABA alleles and AKR1C3 genotype in moderating the treatment response will also be examined. Component VI describes a program of translational, dissemination and educational activities that are integrated with the Center's theme, investigators, and research programs. Finally, the proposed pilot studies component (VII) will support six studies that relate directly to the Center' themes of vulnerability and novel treatments for alcohol dependence and help better position the Center with respect to the new UCONN capital improvement (Bioscience CT) and science (Jackson Laboratories) initiatives.

View original record on NIH RePORTER →